Evidence map›Paper›PMID 41381411›Full record

ArticleJournal of cellular and molecular medicine2025

Investigation of the Characteristics of Telomere Length in Koreans and Its Association With Chronic Metabolic Disorders: A Comprehensive Study.

Seung-Beom Chae, Si Nae Park, Ji-Hoon Lee, Jin-Tae Kim, Min-Jung Song

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seung-Beom ChaeDepartment of BT Research Institute, U2Bio Co. Ltd., Seoul, Korea.ORCID 0000-0002-3098-478X
Si Nae ParkDepartment of BT Research Institute, U2Bio Co. Ltd., Seoul, Korea.ORCID 0009-0008-8644-8813
Ji-Hoon LeeDepartment of BT Research Institute, U2Bio Co. Ltd., Seoul, Korea.ORCID 0009-0005-1943-4268
Jin-Tae KimDepartment of BT Research Institute, U2Bio Co. Ltd., Seoul, Korea.
Min-Jung SongDepartment of BT Research Institute, U2Bio Co. Ltd., Seoul, Korea.ORCID 0009-0007-4238-5112

Funding

U2Bio CO. LTD.
6 · The paper itself

Abstract

Telomeres are repetitive DNA sequences located at the ends of eukaryotic chromosomes, forming protective caps that prevent chromosomal degradation and inappropriate repair during cell division. Telomere shortening has been linked to ageing and various age-related diseases. In this study, we validated the reference range for telomere length established through the analysis of 1011 Korean individuals to confirm its robustness. Telomere length showed a declining trend with increasing age, with no statistically significant differences observed between sexes. Diabetic and dyslipidaemic groups had shorter telomeres than the control group. These findings suggest that telomere length may be a biomarker of biological ageing and could be linked to metabolic conditions. Future research could build upon these observations to explore telomere dynamics in broader populations and investigate their clinical relevance across diverse health outcomes. Furthermore, longitudinal studies are needed to determine whether telomere shortening is a cause or consequence of these metabolic conditions. Additionally, incorporating advanced methodologies, such as next-generation sequencing, could enhance our understanding of telomere biology and improve the accuracy of telomere-based measurements in both research and clinical settings.

Indexed as

Metabolic DiseasesTelomereTelomere HomeostasisTelomere ShorteningAdultAgedAgingChronic DiseaseEast Asian PeopleFemaleHumansMaleMiddle AgedRepublic of KoreaageingdiabetesdyslipidaemiaqPCRtelomereT/S ratio

Identifiers

PMID41381411
PMCPMC12698329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.